What typically occurs in patients with severe bilateral optic neuritis?

In patients with severe bilateral optic neuritis, the administration of intravenous corticosteroids is often necessary to reduce inflammation and promote recovery of vision. Optic neuritis, which is commonly associated with multiple sclerosis, involves inflammation of the optic nerve, leading to vision loss and other symptoms such as pain. The use of systemic corticosteroids can help expedite vision recovery and decrease the duration of symptoms.

Immediate vision improvement is not typically seen; rather, recovery may take time following treatment. Topical treatments alone are insufficient for managing severe cases where systemic inflammation exists; thus, IV corticosteroids are indicated for their potent anti-inflammatory effects. Meanwhile, continual asymptomatic vision would not be expected in the presence of severe optic neuritis, as the condition usually manifests with significant visual impairment. Therefore, the use of IV corticosteroids is aligned with standard treatment protocols for this serious condition.